Treatment of Scalp Fungal Infection (Tinea Capitis)
Oral antifungal therapy is required for treating scalp fungal infections—topical therapy alone is not recommended. 1
Diagnostic Confirmation
Before initiating treatment, obtain specimens for laboratory confirmation:
- Collect scalp samples using scalpel scraping, hair plucking, brush sampling, or swabs 1
- Send for microscopy and culture on Sabouraud agar to identify the specific dermatophyte species 1
- Wood's lamp examination can identify Microsporum canis infections, which fluoresce under ultraviolet light 1
- Dermoscopy may reveal "comma-shaped" hairs in ectothrix infections or "corkscrew" hairs in Afro-Caribbean patients 1
When to Start Treatment
Begin treatment immediately if you observe:
- A kerion (painful, boggy, inflammatory scalp mass with pustules) 1
- Strong clinical suspicion with typical features: scaling, regional lymphadenopathy, or alopecia 1
- High-risk populations where waiting 2-4 weeks for culture results would increase transmission 1
Otherwise, wait for microscopy or culture confirmation before starting therapy 1
First-Line Oral Therapy
Griseofulvin (Licensed Treatment)
Griseofulvin remains the only licensed medication for tinea capitis in children in many countries 1, 2:
- Dosing: 20-25 mg/kg/day in single or divided doses 1, 3
- Duration: 6-8 weeks for most infections 1, 3, 2
- Administration: Take with fatty food to improve absorption 1
- Indications: Effective against Trichophyton and Microsporum species causing tinea capitis 2
Terbinafine (Alternative)
Consider terbinafine if griseofulvin is unavailable or ineffective 3:
- Duration: Weight-based dosing for 4 weeks 3
- Note: Unlicensed for children in some countries but widely used 1
Adjunctive Topical Therapy
Topical antifungal shampoos reduce spore transmission but cannot cure the infection alone 1:
Use these to prevent spread to household contacts and reduce environmental contamination 1
Treatment Duration and Monitoring
Continue treatment until mycological clearance is documented, not just clinical improvement 3:
- Repeat fungal culture at the end of the standard treatment period 3
- Extend therapy if cultures remain positive or if treating resistant organisms like Trichophyton verrucosum (may require up to 3 weeks of incubation for culture) 1
- Increase griseofulvin dose to 25 mg/kg/day for resistant cases 1
Special Clinical Scenarios
Kerion Presentation
For severe inflammatory kerion:
- Start oral antifungals immediately without waiting for culture 1
- Consider oral corticosteroids if inflammation is severe (though not explicitly detailed in guidelines, this is common practice)
- Rule out secondary bacterial infection, which can complicate kerion 1
Treatment Failure
If initial therapy fails 1:
- Verify compliance and adequate dosing
- Confirm the organism through repeat culture
- Switch agents or prolong treatment duration based on culture results
- Consider alternative oral antifungals such as itraconazole or fluconazole (though less commonly used) 4, 5
Infection Control Measures
Prevent transmission and reinfection 3:
- Screen household contacts for asymptomatic carriage, especially with anthropophilic species like T. tonsurans 3
- Disinfect fomites: combs, brushes, hats, and pillowcases 3
- Provide antifungal shampoo to household contacts 3
- Avoid sharing personal items 3
Common Pitfalls
- Do not use topical therapy alone—it will fail to eradicate the infection from hair follicles 1
- Do not stop treatment when symptoms improve; continue until mycological cure is confirmed 3
- Do not confuse with dandruff or seborrheic dermatitis, which can present with similar diffuse scaling 6
- Do not misdiagnose kerion as bacterial abscess, though secondary bacterial infection should be considered 1
- Antifungal susceptibility testing is not routinely indicated, as resistance is rare 1